GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Achillion Pharmaceuticals, Inc. (ACHN) [hlAlert]

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, it focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the
treatment of resistant bacterial infections. As of December 31, 2008, Achillion focused its efforts on advancing two late-stage preclinical candidates: ACH-1095, an NS4A antagonist for the treatment of chronic hepatitis C, being developed in collaboration with Gilead Sciences, Inc. (Gilead), and ACH-1625, a protease inhibitor also for the treatment of chronic hepatitis C. It has a pipeline of other product candidates, for which it is seeking appropriate collaborative partners. These product candidates include elvucitabine for the treatment of human immunodeficiency virus (HIV) infection and ACH-702 for the treatment of serious bacterial infections.
.
( Total: 15 Current Stock Recommendations )
Achillion Pharmaceuticals, Inc.   (15)
Sell Hold 27% Buy 67%
Related companies
Astrazeneca Plc   (20)
Sell 30% Hold 40% Buy 30%
Glaxosmithkline Plc   (19)
Sell 16% Hold 63% Buy 21%
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/31/2007  
Buy
  
10/30/2008  
None
  
1/27/2009  
Buy
  
4/14/2009  
Buy
  
8/7/2009  
Hold
  
2/2/2010  
Buy
  
2/25/2010  
Buy
  
7/26/2011  
Buy
  
1/10/2012  
Buy
  
9/19/2012  
Buy
  
9/30/2013  
Sell
  
9/30/2013  
Hold
  
10/16/2013  
Hold
  
6/12/2014  
Buy
  
12/23/2014  
Hold
  
8/13/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy